PFD exhibited an anti-fibrotic effect by decreasing pro-fibrotic cytokines (like TGF-β1) and anti-proliferative and anti-oxidant features, which reduce progression of IPF via several mechanisms. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.